Risks and case registers in perinatal psychiatry
Puerperal psychosis (Jones 2009 ) is a psychiatric emergency in which assessing and managing risks is paramount. First is the risk of suicide by the mother. Suicide is the leading cause of maternal mortality in the UK, accounting for 28% of the deaths. Women who take their own lives in the postpartum period tend to use violent methods such as hanging or jumping. This contrasts with the usual finding that women who are not in the postpartum period are more likely to die from an overdose of medication. Also compared with the other causes of maternal death, those who die by suicide tend to be older and socially advantaged. This reflects the severity of the illness and also calls into question the so-called 'protective effects of maternity ' (Oates 2003) .
Second is the risk of physical harm to the baby. Infants are at risk from neonaticide, infanticide and filicide, particularly in new-onset psychosis or relapse of psychosis during the postpartum period. Mothers who commit neonaticide are mostly troubled by psychosis and social problems, whereas infanticide and filicide are commonly associated with postpartum depression (Oakley 2009). In the unfortunate event that a woman causes the death of her newborn, the Infanticide Act 1922 and the revised Infanticide Act 1938 can be used to reduce the charge from culpable homicide to manslaughter, if it can be proven in a court of law that 'at the time of the act or omission the balance of [the mother's] mind was disturbed by reason of her not having fully recovered from the effect of giving birth to the child or by reason of the effect of lactation consequent upon the birth of the child'.
Third are risks to both mother and infant (during the gestation period and also postpartum) posed by psychotropic medication. The USA Food and Drug Administration rates drugs in five categories (A, B, C, D and X). Valproic acid is listed in category X ('proved risk in humans (no indication for use, even in life threatening situations'); lithium is listed in category D ('human fetal risk seen (may be used in life threatening situation)'); haloperidol and chlorpromazine are listed in category C (Sadock 2007: pp 865-7). The risks and benefits of treatment with psychotropics versus maternal psychiatric illness must be carefully evaluated on an individual basis. Recently in the USA, GlaxoSmithKline, manufacturer of paroxetine, was ordered to pay $2.5 m to the mother of a child with birth defects (Tanne 2009).
Case registers in pregnancy might be helpful in several ways (Yadav 2009 
The problem of community treatment orders
According to Allen (2009) , the care programme approach (CPA) is a bureaucratic device, not a legal necessity, which has in effect been downgraded since October 2008. The alternative is Section 47 under the National Health Service and Community Care Act 1990.
What is less clear is how the CPA or Section 47 would link up with another new instrument of the Mental Health Act 1983 (as amended in 2007), community treatment orders (CTOs), which the author does not mention.
Someone on a CTO would presumably be diagnosed as extremely ill, and would be more in need of Section 47 provisions. It would be shocking if placement on a CTO, which restricts the freedom of a patient so much, did not guarantee greater access to resources even though they may be scarce (for example, direct payments and housing).
Illumination Although CTOs are now law, they have a poor evidence base (Jethwa 2008) . Some psychiatrists believe that they are not a magic cure for the revolving door syndrome (Lawton-Smith 2008) . The unexpectedly large numbers put onto community treatment orders (Rugkåska 2009) call for another article in Advances, on how CTOs link up with community care law revolving round Section 47.
